Designed for semi-quantitative determination of SARS CoV-2 antigen (nucleocapsid protein) in clinical samples for the diagnosis of coronavirus infection.
Differential diagnosis of the etiology of acute respiratory infection.
For the qualitative detection of IgG to the SARS-CoV‑2 glycoprotein S (spike).
Designed for semi-quantitative and/or quantitative determination of IgG to the receptor-binding domain (RBD-part) of glycoprotein S of SARS-CoV-2 coronavirus.
Evaluation of post-infectious and post-vaccination immunity.